COMMUNIQUÉS West-GlobeNewswire

Coherus BioSciences Management to Present at BMO’s Prescriptions for Success Healthcare Conference
01/12/2017
REDWOOD CITY, Calif., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ) today announced that senior management will be participating in a fireside chat at the BMO Prescriptions for Success [...]
AIT Therapeutics Announces Publication of Its Phase 2 Trial in Bronchiolitis Patients in the Pediatric Pulmonology Journal
01/12/2017
NEW YORK, Dec. 01, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with serious lung [...]
Canada House Wellness Group Announces Increase in Convertible Debenture Unit Financing to $6 Million
01/12/2017
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) is pleased [...]
Caladrius Biosciences to Present at the 10th Annual LD Micro Main Event
01/12/2017
BASKING RIDGE, N.J., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
3D Signatures Inc. Announces Upsizing of $1,500,000 Private Placement, the Appointment of a New Director and Reports on AGM Results
01/12/2017
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 01, 2017 (GLOBE NEWSWIRE) -- 3D Signatures Inc. (TSX-V: DXD ) (OTCQB:TDSGF) (FSE:3D0) (the " Company " or " 3DS ") [...]
Aphios is Developing a Platform for the Delivery of siRNA-based Therapeutics Towards an HIV Cure
01/12/2017
WOBURN, Mass., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Aphios Corporation today announced that it is developing a platform for the effective targeted delivery of siRNA-based Therapeutics with funding from the National [...]
Extendicare Announces Appointment of Al Mawani to Board of Directors
01/12/2017
MARKHAM, Ontario, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) today announced the appointment of Al Mawani to its Board of Directors, effective immediately, for a term [...]
Athenex Announces Planned Retirement of Chief Financial Officer Nick Riehle
01/12/2017
BUFFALO, N.Y., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
California Medical Groups Honored for High-Quality Care of Medicare Advantage Patients
01/12/2017
OAKLAND, Calif., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Almost a third of medical groups statewide achieved top honors for providing high-quality care to Medicare Advantage patients, according to the Integrated Healthcare [...]
AzurRx BioPharma to Present at the 2017 LD Micro 10th Annual Main Event Conference (December 5th)
01/12/2017
BROOKLYN, N.Y., Dec. 01, 2017 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc.(NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
Faron Pharmaceuticals Oy: Appointment of Chief Commercial Officer
01/12/2017
Faron Pharmaceuticals Oy ("Faron" or the "Company") Appointment of Chief Commercial Officer Dr. Juhana Heinonen, previously AstraZeneca's Global Marketing Director, to steer commercialisation strategy for Faron's lead [...]
Curis Announces Upcoming Presentation at the American Society of Hematology 59th Annual Meeting & Exposition
01/12/2017
LEXINGTON, Mass., Dec. 01, 2017 (GLOBE NEWSWIRE) -- Curis, Inc. (NASDAQ: CRIS ), a biotechnology company focused on the development and commercialization of innovative and effective therapeutics for the treatment of [...]
Arog Pharmaceuticals Receives FDA Fast Track Designation for Crenolanib in Relapsed or Refractory FLT3-Positive AML
01/12/2017
DALLAS, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Arog Pharmaceuticals, Inc., a privately held, clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs to treat unmet [...]
Axsome Therapeutics Announces $9.5 Million Registered Direct Offering Priced At-the-Market
01/12/2017
NEW YORK, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Notice Received Under Section 249D of the Corporations Act
01/12/2017
MELBOURNE, Australia, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“Company”), advises that on 29 November it received a notice under Section 249D of the Corporations Act [...]
Employee elected board member change in Zealand Pharma
01/12/2017
Company announcement - No. 54/2017 Employee elected board member change in Zealand Pharma Copenhagen, December 1, 2017 - Zealand Pharma A/S ("ZEAL") announces that Rasmus Just, Director of Business Development and [...]
Photocure ASA: Blue Light Flexible Cystoscopy with Cysview® Phase 3 study: New data presented at Society of Urological Oncology
01/12/2017
Oslo, Norway, December 1, 2017 Photocure ASA (OSE: PHO) announced today that more detailed data from the Phase 3 study data was presented at the prestigious Society of Urologic Oncology, Annual Meeting November 29 - [...]
Nexstim Plc Appoints Steve Beller as Vice President and General Manager, North America
01/12/2017
Company announcement, Helsinki, 1 December 2017 at 9 am Nexstim Plc Appoints Steve Beller as Vice President and General Manager, North America Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical [...]
Basilea extends existing license agreement with Pfizer for antifungal Cresemba® (isavuconazole) to China and Asia Pacific
01/12/2017
Basilea eligible to receive additional upfront and milestone payments of up to USD 226 million and mid-teen royalties on sales Basilea updates its financial guidance for 2017 - improved result expected Basel, [...]

Pages